Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy.

@article{Gurbel2012PlateletFD,
  title={Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy.},
  author={Paul A Gurbel and David Erlinge and E. Magnus Ohman and Benjamin Neely and Megan L. Neely and Shaun G. Goodman and Kurt Huber and Mark Yan Yee Chan and Jan Hein Cornel and Eileen B. Brown and Chunmei Zhou and Joseph A. Jakubowski and Harvey Douglas White and Keith A. A. Fox and Dorairaj Prabhakaran and Paul Wayne Armstrong and Udaya S. Tantry and Matthew T. Roe},
  journal={JAMA},
  year={2012},
  volume={308 17},
  pages={1785-94}
}
CONTEXT The relationship of platelet function testing measurements with outcomes in patients with acute coronary syndromes (ACS) initially managed medically without revascularization is unknown. OBJECTIVE To characterize the differences and evaluate clinical outcomes associated with platelet reactivity among patients with ACS treated with clopidogrel or prasugrel. DESIGN, SETTING, AND PATIENTS Patients with medically managed unstable angina or non-ST-segment elevation myocardial infarction… CONTINUE READING